Free Trial

Inhibikase Therapeutics (IKT) SEC Filings & 10K Form

Inhibikase Therapeutics logo
$2.19 -0.10 (-4.37%)
Closing price 03/31/2025 04:00 PM Eastern
Extended Trading
$2.19 0.00 (0.00%)
As of 03/31/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Inhibikase Therapeutics SEC Filings

DateFilerForm TypeView
03/27/2025
4:01 PM
Inhibikase Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/24/2025
7:14 AM
Inhibikase Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2025
7:16 PM
Freeman Roy Lester (Reporting)
Inhibikase Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
7:18 PM
Bellini Roberto (Reporting)
Inhibikase Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
7:19 PM
Inhibikase Therapeutics (Issuer)
Kush Arvind (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
7:24 PM
Inhibikase Therapeutics (Issuer)
Iwicki Mark T (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/19/2025
7:26 PM
Inhibikase Therapeutics (Issuer)
Iwicki Mark T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
7:00 PM
BERMAN DENNIS N (Reporting)
Inhibikase Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
7:06 PM
BERMAN DENNIS N (Reporting)
Inhibikase Therapeutics (Issuer)
Form 4/A
02/19/2025
7:11 PM
Canner David (Reporting)
Inhibikase Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
7:11 PM
Inhibikase Therapeutics (Issuer)
Munshi Amit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
7:09 AM
Inhibikase Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
8:04 PM
ADAR1 Capital Management, LLC (Filed by)
Inhibikase Therapeutics (Subject)
Form SCHEDULE 13G
02/14/2025
4:35 PM
ARMISTICE CAPITAL, LLC (Filed by)
Inhibikase Therapeutics (Subject)
Form SCHEDULE 13G/A
02/14/2025
2:45 PM
Fairmount Funds Management LLC (Filed by)
Inhibikase Therapeutics (Subject)
Form SCHEDULE 13G/A
02/04/2025
3:06 PM
Inhibikase Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/29/2025
3:05 PM
Inhibikase Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/22/2025
3:05 PM
BERMAN DENNIS N (Reporting)
Inhibikase Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
3:05 PM
Inhibikase Therapeutics (Issuer)
Werner Milton H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
3:05 PM
Freeman Roy Lester (Reporting)
Inhibikase Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
3:05 PM
Inhibikase Therapeutics (Issuer)
Lees-Rolfe Garth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2025
11:15 PM
Inhibikase Therapeutics (Filer)
Form EFFECT
01/10/2025
3:37 PM
Inhibikase Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/07/2025
5:39 PM
Freeman Roy Lester (Reporting)
Inhibikase Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
5:43 PM
Inhibikase Therapeutics (Issuer)
Lees-Rolfe Garth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
5:47 PM
Inhibikase Therapeutics (Issuer)
Werner Milton H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
5:38 PM
BERMAN DENNIS N (Reporting)
Inhibikase Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
5:06 AM
Inhibikase Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2024
11:15 PM
Inhibikase Therapeutics (Filer)
Form EFFECT
12/05/2024
3:47 PM
Inhibikase Therapeutics (Filer)
Form 424B3
12/05/2024
3:50 PM
Inhibikase Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2024
5:24 AM
Inhibikase Therapeutics (Filer)
Form S-3/A
11/18/2024
3:49 PM
Inhibikase Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/14/2024
7:30 AM
Inhibikase Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2024
3:07 PM
Inhibikase Therapeutics (Filer)
Form PRE 14A
10/28/2024
4:26 PM
Inhibikase Therapeutics (Subject)
SP IKT Holdings LLC (Filed by)
Form SC 13G
10/28/2024
3:00 PM
Inhibikase Therapeutics (Subject)
Soleus Private Equity Fund III, L.P. (Filed by)
Form SC 13G
10/25/2024
4:52 PM
Inhibikase Therapeutics (Issuer)
Sands Capital Life Sciences Pulse Fund II, L.P. (Reporting)
Sands Capital Ventures, LLC (Reporting)
SANDS FRANK M. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/25/2024
4:50 PM
Inhibikase Therapeutics (Subject)
Sands Capital Life Sciences Pulse Fund II, L.P. (Filed by)
Form SC 13G
10/23/2024
6:58 PM
Canner David (Reporting)
Inhibikase Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2024
6:35 PM
Bellini Roberto (Reporting)
Inhibikase Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
Musk’s real agenda in D.C. (Ad)

In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of America…

10/23/2024
6:36 PM
Inhibikase Therapeutics (Issuer)
Munshi Amit (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/23/2024
6:38 PM
Canner David (Reporting)
Inhibikase Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/23/2024
6:40 PM
Inhibikase Therapeutics (Issuer)
Kush Arvind (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/23/2024
6:43 PM
Inhibikase Therapeutics (Issuer)
Munshi Amit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2024
6:49 PM
Inhibikase Therapeutics (Issuer)
Kush Arvind (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2024
6:53 PM
Bellini Roberto (Reporting)
Inhibikase Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
3:15 PM
Inhibikase Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13G
10/21/2024
8:13 PM
Inhibikase Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
6:00 PM
Fairmount Funds Management LLC (Filed by)
Inhibikase Therapeutics (Subject)
Form SC 13G
10/17/2024
3:05 PM
COMMODORE CAPITAL LP (Filed by)
Inhibikase Therapeutics (Subject)
Form SC 13G
10/10/2024
4:31 PM
Inhibikase Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2024
7:40 AM
Inhibikase Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2024
8:21 PM
Inhibikase Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2024
4:23 PM
Dion Gisele (Reporting)
Inhibikase Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
4:27 PM
GRINT PAUL C (Reporting)
Inhibikase Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
4:18 PM
Freeman Roy Lester (Reporting)
Inhibikase Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
4:20 PM
BERMAN DENNIS N (Reporting)
Inhibikase Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2024
8:25 PM
Inhibikase Therapeutics (Filer)
Form 424B3
06/26/2024
11:15 PM
Inhibikase Therapeutics (Filer)
Form EFFECT
06/21/2024
3:30 PM
Inhibikase Therapeutics (Filer)
Form DEFA14A
06/20/2024
5:06 PM
Inhibikase Therapeutics (Filer)
Form DEF 14A
06/18/2024
4:27 PM
Inhibikase Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
06/10/2024
3:20 PM
Inhibikase Therapeutics (Filer)
Form PRE 14A
05/22/2024
7:55 AM
Inhibikase Therapeutics (Filer)
Form 424B5
05/20/2024
7:55 AM
Inhibikase Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2024
6:09 AM
Inhibikase Therapeutics (Filer)
Form 424B5
05/15/2024
6:56 AM
Inhibikase Therapeutics (Filer)
Form RW
05/09/2024
1:41 PM
Inhibikase Therapeutics (Filer)
Form S-1/A
04/30/2024
7:17 AM
Inhibikase Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2024
3:20 PM
Inhibikase Therapeutics (Filer)
Form ARS
04/26/2024
3:15 PM
Inhibikase Therapeutics (Filer)
Form DEF 14A
04/25/2024
3:29 PM
Inhibikase Therapeutics (Filer)
Form S-1/A
04/19/2024
4:14 PM
Inhibikase Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
04/18/2024
8:46 PM
Inhibikase Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2024
4:12 PM
Inhibikase Therapeutics (Filer)
Form 8-K/A
04/02/2024
4:12 PM
Inhibikase Therapeutics (Issuer)
Lees-Rolfe Garth (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/02/2024
4:14 PM
Inhibikase Therapeutics (Issuer)
Lees-Rolfe Garth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NYSE:IKT) was last updated on 4/1/2025 by MarketBeat.com Staff
From Our Partners